HOME >> BIOLOGY >> NEWS
Relapses Prevented In Mouse Model Of Multiple Sclerosis: Research Aimed At,,Treating Relapses In Human MS

Researchers at the University of Pennsylvania Medical Center have discovered that antibodies to a common inflammatory-response protein can prevent relapses in an animal model of human multiple sclerosis. "We have been able to prevent relapses in the mouse version of multiple sclerosis using anti-interleukin-12 antibodies for the first time," says Mohamad Rostami, MD, PhD, professor of neurology at Penn's School of Medicine. "Most treatments for MS are first tried out in the experimental allergic encephalomyelitis, or EAE, animal model of MS, before being tested in humans, so this research represents another possible therapy for MS patients." Rostami, Cris Constantinescu, a doctoral student in Rostami's laboratory, and colleagues report their findings in the November 1 issue of the Journal of Immunology.

MS, a neurological disorder, affects 300,000 or more young adults in the United States. Many with the disease suffer from relapses after the initial onset of such symptoms as numbness and paralysis. Trying to remedy these relapses is the research focus of Rostami and his collaborators.

Although the origins of MS remain mysterious, the disorder is considered an autoimmune disease. Immune system cells called T cells cause inflammation in the brain and spinal cord, which is eventually followed by demyelination, the breakdown of the protective sheath that surrounds nerve axons. Certain T cells work in conjunction with proteins called cytokines to cause the damage. "In brains of EAE mice, we saw that the cytokine interleukin-12 is upregulated when there's a relapse and downregulated during a remission," says Rostami. "We believe that both MS and EAE are induced by the Th1 type of T cell. Th2 cells, another type of T cell, are important for recovery from inflammation."

As part of MS-induced inflammation Th2s will try to fight the damage that Th1 cells cause. Rostami reasoned that if the cytokine balance could be changed to decre
'"/>

Contact: Karen Young Kreeger
kreeger@mail.med.upenn.edu
215-614-0290
University of Pennsylvania School of Medicine
28-Oct-1998


Page: 1 2

Related biology news :

1. U.S. In The Midst Of A Heroin Epidemic, But Many Overdose Deaths Can Be Prevented
2. Cell Suicide Prevented By Survival Signals
3. Half-million dollar landmark achieved for the Methuselah Mouse Prize
4. Mouse study shows NPAS3 and NPAS1 genes may be linked to psychosis
5. Mouse brain stem cells capable of converting into blood vessel cells
6. Mouse study yields clue to why liver is less prone to rejection, say Pitt researchers
7. Mouse embryonic germ cells and male gametes created in the lab
8. Mouse, stripped of a key gene, resists diabetes
9. Mouse model of schizophrenia could speed identification of new antipsychotic drugs
10. Mouse study identifies protective mechanism against alcohol-induced embryo toxicity
11. Mouse model offers new explanation for kidney disease and failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2019)... , ... April 30, 2019 , ... ... LLP is pleased to announce that Gunes Bender, Ph.D., a registered patent ... sciences practice group. In his new role, Bender provides technical support and scientific ...
(Date:4/27/2019)... ... April 26, 2019 , ... Washington State University’s Center for ... than 30 student venture teams, representing nearly 150 students, presented their business ideas ... The top five teams in the College League were awarded prize money with ...
(Date:4/25/2019)... , ... April 24, 2019 , ... ... Services Secretary Alex Azar today, a broad collective of 62 individual scientists, bioethicists, ... American Society of Gene & Cell Therapy (ASGCT), across industry and academia called ...
Breaking Biology News(10 mins):
(Date:4/18/2019)... , ... April 18, 2019 , ... ... a research team that includes a chemical engineer at Worcester Polytechnic Institute (WPI) ... that may make it possible to manufacture isobutanol and other biofuels more economically. ...
(Date:4/12/2019)... (PRWEB) , ... April 12, 2019 , ... ... recent developments in neurotechnology and will educate about innovative tools and devices being ... your local listings for more information. , This segment of Advancements will focus ...
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny ... for approximately two months. After a series of diagnostics, an MRI was performed ... owner, Alison, researched the injury and found that VetStem Regenerative Cell Therapy ...
(Date:4/8/2019)... ... April 09, 2019 , ... ... innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics ... repertoires is part of CZ Biohub’s efforts to establish new approaches to inform ...
Breaking Biology Technology:
Cached News: